Biocide TRIZ Cases

Low pH control below 6 prevents saflufenacil hydrolysis while surfactants maintain suspension homogeneity during storage.

A synergistic mixture of alkoxypyrazole compounds and dicyandiamide inhibits soil nitrification through combined enzymatic blocking.

Amino acid vitamin ester compositions form precipitable drug depots upon injection, eliminating blood level fluctuations and side effects from frequent dosing.

A Chitinophaga pinensis strain produces phytohormones and osmolytes to enhance plant tolerance against water stress.

Segmenting synthesis into distinct steps improves production efficiency while maintaining process control for large-scale manufacturing.

Triglyceride fatty acid esters and surfactants form stable emulsions that increase spray droplet size, reducing off-target drift from hydraulic nozzles.

Novel di(amido-substituted)heteroarene compounds enhance ALP activity and osterix mRNA expression to treat osteoporosis with low cytotoxicity.

Formula I compounds inhibit matriptase to reduce tumor growth and metastasis while sparing normal cells.

A glyphosate and phosphite mixture protects genetically engineered crops from herbicide toxicity.

End-capped polymeric guanidine minimizes terminal amino groups to lower mammalian toxicity and endocrine disruption while maintaining antimicrobial efficacy.

Segmented release carriers lower peak plasma concentrations to reduce vestibular and gastrointestinal side effects while maintaining acne treatment efficacy.

Wheat variety W020088N1 utilizes molecular marker-assisted selection to accelerate genetic stability and uniformity.

Aqueous dispersion of cationic polymer particles incorporates water-insoluble insecticides via radical emulsion polymerization.

Selective 4-amino-1H-pyrimidin-2-one inhibitors block viral nucleoside activation while preserving chemotherapeutic efficacy.

Bicyclic compounds targeting CXCR4 receptors address inadequate therapeutic outcomes in age-related macular degeneration and diabetic retinopathy.

Structure A compounds inhibit chlorosis and necrosis, maintaining seed viability during storage.

Granular pesticide compositions utilize precipitated silica carriers to absorb active ingredients, resolving toxicity and dispersion contradictions.

Tricyclic heteroaromatic compounds modulate SDF-1 binding to CXCR4 and CCXCKR2, addressing the lack of effective small molecule inhibitors for cancer and HIV.

Isolating specific cyclohexanol ether isomers eliminates complex mixtures, improving stability and lowering production costs.

Optimized BAM pharmaceutical combination resolves tissue injury trade-offs while ensuring complete anesthesia and immobilization.

Replacing the phenolic 3-hydroxyl group with small polar residues maintains pharmacological activity while allowing structural modification flexibility.

Transdermal vitamin D3 formulation delivers reliable pain relief for neurogenic inflammation while avoiding undesirable side-effects of systemic treatments.

A synergistic herbicidal composition combines Pyroxasulfone, Topramezone, and Atrazine to enhance weed control efficacy.

GhJAZ protein fused with NGR peptide targets APN receptors on insect pests to deliver insecticidal activity.

Lecithin and dispersants stabilize agrochemical concentrates against separation when mixed with liquid fertilizers.

Histone deacetylase inhibitors decrease cellular DNA repair activity by targeting RAD51, reducing required doses of DNA-damaging agents.

Swellable particles dehydrate to 5 μm for pulmonary delivery, then swell to 6 μm to prevent macrophage phagocytosis.

Formula I and II compounds inhibit p38 kinase to reduce pro-inflammatory cytokine levels, addressing side effects from existing treatments.

A chemical composition containing five specific compounds attracts bed bugs for detection.

Formula I heterocyclic compounds address insufficient efficacy and specificity in existing pest control agents through parameter changes.

Polyprenols inhibit MAO and BuChE enzymes, addressing underlying neuronal damage while reducing side effects compared to cholinesterase inhibitors.

Diindolylmethane compounds replace toxic organotins to prevent marine fouling without harming non-target organisms.

Sequential oncolytic virus and anti-angiogenic therapy induces vascular shutdown to overcome cancer cell resistance.

Dissolving prohexadione in an ionic liquid overcomes water solubility limits to ensure long-term storage stability.

N-methylaminomethyl isoindole compounds inhibit angiogenesis and cytokine production to treat refractory cancers with reduced side effects.

Transdermal patches use permeation enhancers to move glucosamine through the skin barrier, increasing bioavailability by avoiding first-pass metabolism.

Tetrahydrocyclopenta[b]indole compounds modulate androgen receptors to treat hypogonadism while minimizing prostate stimulation.

Varying estrogen doses across three phases stabilizes the endometrium to prevent breakthrough bleeding during extended contraceptive cycles.

Modified heterocyclic structures inhibit metastatic signaling and HIV entry while improving oral bioavailability.

Cannabidiol resolves partial relief trade-offs by inducing immune cell apoptosis and suppressing T cell proliferation without psychotropic effects.

Novel thieno[2,3-d]pyrimidine compounds act as selective A2A adenosine receptor antagonists.

A CD33 inhibitor antibody reduces functional CD33 expression to modulate microglial activation.